Fund profile
Boulder Ventures
Boulder, United States
Leading
About
Boulder Ventures, established in 1995, is a venture capital firm that focuses on investing in early-stage information technology and life sciences companies. With headquarters in Boulder, Colorado, and an office in the Mid-Atlantic region, the firm leverages decades-long relationships with entrepreneurs and investors to drive its investment strategy. Boulder Ventures has raised eight funds totaling approximately $429 million, with the most recent fund, Boulder Ventures VIII, closing at $58 million in 2022. The firm has a notable track record, having invested in 61 companies, leading to 28 exits and 10 IPOs. Key investments by Boulder Ventures include companies like Array BioPharma (acquired by Pfizer for $11.8 billion), LeftHand Networks (acquired by HP), and Wall Street on Demand (acquired by Goldman Sachs). The firm’s portfolio is diverse, covering sectors such as software, IT services, storage and communications, and life sciences. Kyle Lefkoff, the founder and general partner, brings over 38 years of venture capital experience. His extensive background includes significant roles in guiding companies through critical growth stages and strategic exits.
Details
Highlights
$2.1M
Historical average check
$118M
Historical max check
December 2023
Last investment date
101
Investments
Software & Apps
Healthtech & Wellness
Pharma
Biotech
Hardware. Robotics & IoT
Other
Showing 0 lists
Contacts
Website
boulderventures.comSocial
Lists that include this fund